Publications by authors named "W Edward Fiets"

Claim this Profile
N
Neoadjuvant chemoradiotherapy followed by active surveillance versus standard surgery for oesophageal cancer (SANO trial): a multicentre, stepped-wedge, cluster-randomised, non-inferiority, phase 3 trial.
Berend J van der Wilk, Ben M Eyck, Bas P L Wijnhoven, Sjoerd M Lagarde, Camiel Rosman, W Edward Fiets

Lancet Oncol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interval Metastases After Neoadjuvant Chemoradiotherapy for Patients with Locally Advanced Esophageal Cancer: A Multicenter Observational Cohort Study.
Charlène J van der Zijden, Pieter C van der Sluis, Bianca Mostert, Joost J M E Nuyttens, J Jan B van Lanschot, Willem E Fiets

Ann Surg Oncol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Using non-randomized trials to assess the clinical benefit of systemic anti-cancer treatments: Viable or not?
N S H Xander, B Leeneman, A-M C Dingemans, W E Fiets, W K de Jong

Eur J Cancer· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing the clinical benefit of systemic anti-cancer treatments in the Netherlands: The impact of different thresholds for effectiveness.
Brenda Leeneman, Nicolas S H Xander, W Edward Fiets, Wouter K de Jong, Nathalie E M Uyl

Eur J Cancer· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness and budget impact of pembrolizumab+axitinib versus sunitinib in patients with advanced clear-cell renal cell carcinoma in the Netherlands.
Nicolas S H Xander, W Edward Fiets, Carin A Uyl-de Groot

Front Oncol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis